This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
QP-Prostate
FDA 510(k), UKCA, and CE mark-cleared solution for prostate MRI analysis based on Artificial Intelligence.
Quantitative information to increase diagnostic accuracy
QP-Prostate® offers a fundamental change in prostate MRI exams, improving clinical workflow and supporting accurate decision-making. This solution provides robust standardization through an automated prostate segmentation process that generates quantitative, meaningful insights and improves clinical accuracy. The AI-powered tool integrates with PACS and streamlines tasks through automated prostate segmentation, providing quantifiable insights not attainable by the human eye and offering relevant clinical and economic benefits.
The challenge
Clinical Overview
Prostate cancer is a common type of cancer among men and is the second leading cause of cancer death in men worldwide. More than 1.4 million men are diagnosed yearly with prostate cancer, with most cases occurring in men over 65. Prostate MRI, in conjunction with target biopsy, improves the identification of clinically relevant cancer while reducing the number of biopsy cores.
User needs
- An improvement in reducing the number of biopsy cores required.
- Time-consuming process of reading and reporting MRI exams and shortage of radiologists/specialists.
- Increase the number of multiparametric MRI prostate scans performed.
- Ensuring quality and reproducibility of input data
- Need for regular review of acquired images to meet image quality standards
- Need to prioritize the quality of input data and standardize the reporting process.
- Need for tools to support a reproducible and accurate interpretation of prostate MRI exams according to the PI-RADS reporting system.
“Prostate cancer is the second leading cause of cancer death, behind only lung cancer.”
American Cancer Society
The solution
QP-Prostate® is a state-of-the-art medical software that streamlines the reading of prostate MRI exams by providing automated, quantitative image analysis. Using prostate MRI scans to provide automated, quantitative image analysis of the apparent diffusion coefficient (ADC) and perfusion pharmacokinetics (PKM), as well as automatic segmentation of the prostate into different regions, including the Transition + Central Zone (TZ + CZ), the Peripheral Zone (PZ), and the seminal vesicles.
With QP-Prostate®, radiologists can access parametric ADC, Ktrans, Kep, and Ve maps, a volume segmentation of the prostate, and a comprehensive prostate sector map, which can be visualized on DICOM workstations or in PACS. QP-Prostate® provides a complete and standardized structured report following PI-RADS V2.1 for a better reporting experience.
The QP-Prostate® viewer allows for ROI management and annotations of the whole gland and any suspicious findings. In addition, the structured report in PI-RADS v2.1 format offers pre-populated information, including patient history, technical details, prostate gland volume, PI-RADS scoring template, automated ROI metrics, and space to add radiology conclusions with image selection. Therefore, QP-Prostate® is the ideal solution for radiologists of all levels of expertise. The output of QP-Prostate® is provided in DICOM format and could be used for fusion-biopsy purposes for more accurate and precise biopsy results.
Workflow
